Advertisement

Topics

Kenya's Imaginature Seeks Approval for Field Trial of GE Baby's Breath Flowers

13:00 EDT 21 Jun 2017 | ISAAA

Genetically engineered Baby's Breath (Gypsophila) flowers may soon be available in the American market. Commercial cut-flower developer, Imaginature Ltd. is seeking the approval of Kenya's National Biosafety Authority (NBA) to conduct open field trials of GE Gypsophila, which is targeted for the American market. Experts at Imaginature altered the g...

Original Article: Kenya's Imaginature Seeks Approval for Field Trial of GE Baby's Breath Flowers

NEXT ARTICLE

More From BioPortfolio on "Kenya's Imaginature Seeks Approval for Field Trial of GE Baby's Breath Flowers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...